Comparison of Phenol、Para-methyl Phenol and Para-ethyl Phenol Content in Xianzhuli of 8 Originals by HPLC

Abstract

Abstract: Objective： To compare the Phenol、Para-methyl phenol and Para-ethyl phenol content of Xianzhuli of 8 originals and provide a reference for quality standard research of Xianzhuli. Methods：The Phenol、Para-methyl phenol and Para-ethyl phenol content in different original of Xianzhuli were analyzed by HPLC with variable wavelength. Results： The contents of phenol， p-methyl phenol and p-ethyl phenol in Xianzhuli were different from each other， and the contents of Phyllostachys pubescens Mazel ex H.de Leh. var. henonis (Mitford) Stapf ex Rendle.and Phyllostachys glauca McClure were much higher than those of the other five originals. Conclusion： This accurate，stable and reproducible method can provide reference for the quality standard research of Xianzhuli.

Key words: font-size:medium, ">Xianzhuli； Original； High performance liquid chromatography（HPLC）； Content comparative

CLC Number:

XIAO Xiao-wu, ZHOU Zhi-qiang, HONG Ting, FU Hui-zheng, LUO Yue-hua, WANG Wei. Comparison of Phenol、Para-methyl Phenol and Para-ethyl Phenol Content in Xianzhuli of 8 Originals by HPLC[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(5): 386-390.

References

[1]国家药典委员会.中华人民共和国卫生部药品标准[S].北京：中国医药科技出版社，1992：99.
     [2]佚名.神农本草经[M].北京：人民卫生出版社，1956：44-46
     [3]陶弘景. 本草经集注[M].北京：人民卫生出版社，1994：277.
     [4]李时珍.本草纲目[M].太原：山西科学技术出版社，1993：19-24.
     [5]南京中医药大学.中药大辞典[M].上海：上海科学科技出版社，1999：253.
     [6]国家药典委员会.中华人民共和国药典：(一部)[M].北京：人民卫生出版社，1977：635
     [7]徐诗军，万娜，伍振峰，等.黄艺鲜竹沥的本草考证与现代研究进展[J].中国实验方剂学杂志，2021，27，(4)：196-204.
     [8]冯绘敏，胡云飞，曾茜垚，等.4鲜竹沥化学成分及质量控制方法研究进展[J].中国中药杂志，2021，46，(11)：2753-2759.
     [9]金晓飞，李红，将孟良.不同种竹沥的化学组分分析及其药效研究[J].中医药导报，2014，20(5)：82-85.
     [10]姚金龙，付辉政，罗跃华，等.鲜竹沥的化学成分及其对枸橼酸致豚鼠咳嗽的研究[J].南昌大学学报（医学版），2019，59(6)：9-17.
     [11]杨朗生，杨灌英，浦尚饶.鲜竹沥生物活性以及其应用研究进展[J].四川林业科技，2009，30(3)：109-111.
     [12]蔡华芳. 鲜竹沥镇咳祛痰作用的实验研究[J].中国实验方剂学杂志，2007，13(5)：43-44.
     [13]张雨恬，伍振峰，黄艺，等.基于网络药理学与分子对接技术的鲜竹沥治疗“咳、喘、痰”机制及其质量标志物预测分析[J].中草药，2021，52，(24)：7538-7549.
     [14]陈碧莲，祝明，周冯秋.高效毛细管气相色谱法测定鲜竹沥中愈创木酚的含量[J].中成药，2010，8(6)：482-485.
     [15]熊艳，吴学文，蒋孟良.HPLC测定鲜竹沥口服液中愈创木酚的含量[J].中国中药杂志，2007，32(8)：747-748.
     [16]刘绪平.同时测定中药鲜竹沥中的多种止咳化痰活性成分的方法：中国，CN111398507A [P]. 2020-07.
     [17]杨美菊，唐强，吴长华.3种竹子制备鲜竹沥中愈创木酚含量的比较[J].中南药学，2003，25(6)：452-454.
     [18]李红，蒋孟良，刘党生，等.紫外法测定竹沥中总酚含量[J]. 中国现代中药，2008，10(8)：16-17.
     [19]赵雯，洪挺，游媛，等. HPLC-ELSD 同时测定鲜竹沥中单糖双糖的含量[J].中国现代中药，2020， 22(3)： 423-442.

Comparison of Phenol、Para-methyl Phenol and Para-ethyl Phenol Content in Xianzhuli of 8 Originals by HPLC

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	DAI Qi, LI Kang-xi, YE Qiao-bo, WEN Yong-sheng, XU Li, LI Ji. Reaserch Progress on Chemical Constituents，Pharmacological Effects and Toxicology of Bombyx Batryticatus [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 402-408.
[2]	ZHAO Lei, YANG Ming, WANG Hao, MA yu, MA Jin-gan, JIANG Da-cheng, WANG Lu-hong, ZAN Ke. Investigation and Risk Assessment of Mycotoxins in Seabuckthorn during Different Harvesting Periods and Drying Processes [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 377-383.
[3]	HONG Shu-hua, LIN Qi-shan, CHAI Jiang-hong, PAN Hong-ju. Study on the Determination of Zopiclone Related Substances and the Influence of Correction Factor [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 384-388.
[4]	LI Yue-chen, CUI Shao-jing, ZHAO Yue-ran. Determination of Aflatoxins in Huoxuezhitong Capsules by High Performance Liquid Chromatography Coupled with Post-column Photochemical Derivatization [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 390-395.
[5]	TIAN Jie, HAO Ai-yu, LU Lin, ZOU Pian, DONG Bin. Effect of Several Drug Compatibility on Sub-visible Particles in Infusions with Common Plastic Packagings [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 396-401.
[6]	YANG Yan-qing, CHEN Chun-mei, CHEN Wei, Wu Rui, WANG Xue-chang, DUAN Lian. Rapid Health Technology Evaluation of Sintilimab as First-line Treatment for Advanced Non-small Cell Lung Cancer [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 409-415.
[7]	JIANG Yi-Fan, CHEN Li-ping, ZHANG Ruo-yu, WU Pei-hao, QIU Jia-min, XUAN Jian-wei, BI Hui-chang. Construction of Clinical Comprehensive Value Evaluation System for Acid-inhibiting Drugs [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 416-421.
[8]	HUA Min-fan, SONG Cang-sang, LI Xing-de, LU Wei, MAO Pan-pan, WANG Guo-hui. Medication Adherence Forecast Model Research Progress in Clinical Application [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 422-425.
[9]	HUANG Bo, CAO Xiao-ming. Safety Analysis of Isotonic and Hypotonic Contrast Media for Coronary Angiography in Elderly Patients with Renal Impairment [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 426-429.
[10]	ZHANG Wen, YANG Wei-bing. Effects of Vitamin D Combined with Etocoxib on Rehabilitation，Bone Metabolism and Inflammation in Elderly Patients after Knee Replacement [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 430-434.
[11]	TIAN Jin-ya, DUAN Xiao-kai, FAN Shi-zhen. Effects of Budesonide combined with Ipratropium Bromide Solution on Lung Function， Blood Gas Analysis and Th1/Th2 Cytokines with Chronic Bronchitis [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 435-438.
[12]	ZHANG He-feng, LIANG Yu, LIU Ying, ZOU Ling-long, . Introduction of Bioanalytical Strategies and Methodologies for Genetically Modified Cell Therapy Products [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 369-376.
[13]	ZHANG He-feng, LIANG Yu, LIU Ying, ZOU Ling-long, . Bioanalysis of Gene Therapy Products： Method Development Strategy [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 361-368.
[14]	ZHANG Yu, LI Yu-man, XIA Xu-dong. Analysis of Suspected ADR Monitoring Data of Ginkgo Injection Preparations [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(5): 439-444.
[15]	YAO Qing, LIU Ying, WANG Xiao-fang, GAO Ning, WANG Miao. Excel Calculates the Population Bioequivalence of Special Preparations [J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(4): 332-337.